Full identifier: http://purl.org/np/RAcRtJtUdpkNrwhZznQhG7kiCWDkGoViSjmSQrPW7iOFE#association
Assigned to 1 class:
Nanopublication | Part | Subject | Predicate | Object | Published By | Published On |
---|---|---|---|---|---|---|
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
votrient r votrient is indicated for the treatment of patients with advanced soft tissue sarcoma sts who have received prior chemotherapy limitation s of use votrient is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma 1 advanced soft tissue sarcoma who have received prior chemotherapy 1 limitation s of use
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|
||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|
|||
links a nanopublication to its assertion
http://www.nanopub.org/nschema#hasAssertion
assertion
|
association
|
Leoni Bücken
|
2021-06-21T07:59:00.710Z
|